Feature | Breast Biopsy Systems | October 17, 2019 | By Harriet Borofsky, M.D.

Save the Biopsy Suite

A case study of tomosynthesis-guided prone breast biopsies at Mills-Peninsula Women’s Center

A patient prepares to have a tomosynthesis-guided prone breast biopsy using the Hologic Affirm prone biopsy system.

A patient prepares to have a tomosynthesis-guided prone breast biopsy using the Hologic Affirm prone biopsy system.

Harriet Borofsky, M.D.

Harriet Borofsky, M.D.

The current body of research supporting digital breast tomosynthesis (DBT or 3-D mammography) is now overwhelming, with numerous single and multi-institutional studies showing this technology improves screening outcomes and accuracy by increasing breast cancer detection rates, decreasing recall rates and increasing specificity. Since DBT debuted in 2011, its utilization has quickly increased.

A recent JAMA Internal Medicine1 research letter showed that use of DBT for breast cancer screening has grown rapidly, increasing from almost 13 percent of screening exams in 2015 to more than 43 percent in 2017. More than 93 percent of insured women now have coverage for DBT exams. The American Society of Breast Surgeons’ (ASBrS) newly released, updated breast cancer screening guidelines explicitly named DBT as the preferred modality for annual mammography. At this point in time, it is certainly reasonable to say that this technology is now considered the standard of care for both screening and diagnostic mammography.

However, despite the confirmed benefit and widespread acceptance of digital breast tomosynthesis, a gap exists between its utilization and its requirement for tomosynthesis-guided interventional procedures.

A New Challenge

While DBT has significantly improved mammography outcomes, it has also presented new challenges: detection of subtle, but definite areas of architectural distortion and amorphous calcifications seen only on tomosynthesis images without ultrasound correlates that they are not able to be confidently seen and biopsied using 2-D stereotactic biopsy systems. This has led to an increase in non-diagnostic procedures and the need for surgical excisional biopsies.

Thankfully, the introduction and availability of tomosynthesis-guided biopsy technologies has solved this critical problem — first utilizing add-on upright units and more recently with dedicated prone systems.   

The advantage of add-on upright units is the ability to perform tomosynthesis-guided biopsies quickly and efficiently, increasing room functionality. However, they also have the distinct disadvantages of limiting capacity for diagnostic and screening exams, which may lead to backlog and vasovagal reactions, which are common with upright positioning.   

A Case Study of Tomosynthesis-guided Prone Biopsy

New prone tomosynthesis-guided biopsy units now have all the advantages of 3-D localization — improved conspicuity of all lesions (including those only seen on tomosynthesis images), improved efficiency of procedures and lower radiation dose — with the added advantages of a dedicated procedure room to increase overall capacity and prone positioning to reduce concern of vasovagal reactions.

At Mills-Peninsula Women’s Center in California, we’ve found that our ability to perform tomosynthesis-guided prone biopsies has been integral to our reputation as a referral center for all breast procedures and a center of excellence for our patients. Thanks to this technology, we can perform challenging procedures quickly and efficiently.

Difficult Procedures

A recent patient referral to Mills-Peninsula illustrates this: A patient from an outside facility had a baseline screening mammogram detecting suspicious calcifications requiring biopsy, but with breast thickness of 18 mm, making a standard perpendicular approach with core needle biopsy impossible to perform. A surgical excisional biopsy was initially recommended. However, the surgeon referred the patient on to us at Mills-Peninsula, knowing we had the expertise and technology to perform this procedure for this patient.

What was impossible for another facility was now a straightforward and quick procedure thanks to the advancements of tomosynthesis-guided biopsy and the functionality of a lateral arm approach on the prone system.

Thanks to the lateral needle approach, access to parallel needle placement is available, quick and efficient. Essentially any lesion in the breast, even breast tissue that compresses very thin, is accessible for biopsy.

Patient Experience

Tomosynthesis-guided biopsies have had an enormous positive impact on patient experience. Procedures are now quickly and confidently performed because less imaging is needed, the field of view is larger and lesion conspicuity is increased. That means decreased procedure time for the patient with the breast in compression.

Previously, stereotactic biopsies could take 30-45 minutes to complete. This was a frustrating reality of older systems and technologies. However, thanks to newer biopsy technology, procedures can be completed in about 10 minutes.

In achieving this speed, one of the most important considerations is conspicuity of lesions. Whether it is calcifications, architectural distortion, round or irregular masses — if you can target on the first sweep of tomosynthesis images and see the lesion, then you can save a lot of time.

Another consideration is patient comfort. For many, prone systems offer a more compassionate, comfortable experience compared to their upright counterpart. That’s because direct view of the biopsy needle is eliminated with prone systems, helping to reduce worry of vasovagal reaction or other adverse responses.

Improved Workflow

Having a dedicated biopsy suite with a prone biopsy system improves workflow and capacity — something that is especially important at Mills-Peninsula due to our high volume and our patient commitment to have biopsy procedures performed within three days.

Upright biopsy systems decrease capacity for screening and diagnostic mammography, which may impact scheduling, leading to backlogs. For every biopsy conducted on an upright system, a facility loses scheduling for approximately four mammography procedures. This can have an especially negative impact, resulting in patient dissatisfaction, patient out-migration and lost revenue.

Having a prone system in a dedicated biopsy suite eliminates these concerns, allowing for more flexible scheduling, increased capacity for procedures and more efficient workflow.

Increased Capacity

Another benefit of the prone biopsy unit has been increased capacity for these needed procedures.
At Mills-Peninsula, we used to schedule a maximum of three stereos per day. Now we can perform three procedures in the morning and two in the afternoon. It is a real game changer for our facility.

Save the Biopsy Suite

Our experience with tomosynthesis-guided prone biopsy at Mills-Peninsula has solidified our commitment to this technology. While some may perceive benefits in transitioning to upright-only environments, we have experienced the benefits of tomosynthesis-guided prone biopsies at our breast center.

Truly, there is a case to be made to save the biopsy suite, and we have made it.

 

Harriet Borofsky, M.D., is the medical director of breast imaging with Mills-Peninsula Medical Center in San Meteo, Calif. She is a graduate of Harvard Medical School and completed her residency and fellowship at Stanford University Hospital, Calif.

 

Reference:

Adoption of Digital Breast Tomosynthesis in Clinical Practice, I. Richman et al, JAMA Intern Med., doi:10.1001/jamainternmed.2019.1058. Published online June 24, 2019. https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2.... Accessed Aug. 27, 2019.

Related content:

Improving Clinical Image Quality for Breast Imaging

Roundtable: Stereotactic Breast Imaging

Related Content

VolparaEnterprise data analysis shows mammography screening volumes are quickly increasing
News | Mammography | June 09, 2020
June 9, 2020 — More than 75 percent of hospitals and imaging centers that perform mammography across the United State
Developed by medical AI company Lunit, Software detects breast cancer with 97% accuracy; Study in Lancet Digital Health shows that Lunit INSIGHT MMG-aided radiologists showed an increase in sensitivity

Lunit INSIGHT MMG

News | Artificial Intelligence | June 02, 2020
June 2, 2020 — Lunit announced that its artificia...
AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.
Headlines around the world the past several months declared that...
a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of pol

a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of polyethylene microspheres (diameter, 20 μm) dispersed in agar. The inset shows a zoomed-in view of the region boxed with a yellow dashed line. In addition, the yellow boxes are signal profiles along the xy and z axes across the microsphere centre, as well as the corresponding full width at half-maximum values. c Normalized absorption spectra of Hb, HbO2 and gold nanoparticles (AuNPs). The spectrum for the AuNPs was obtained using a USB4000 spectrometer (Ocean Optics, Dunedin, FL, USA), while the spectra for Hb and HbO2 were taken from http://omlc.org/spectra/haemoglobin/index.html. The vertical dashed lines indicate the five wavelengths used to stimulate the three absorbers: 710, 750, 780, 810 and 850 nm. Optoacoustic signals were filtered into a low-frequency band (red) and high-frequency band (green), which were used to reconstruct separate images.

News | Breast Imaging | May 26, 2020
May 26, 2020 — Breast cancer is the most common cancer in women.
Phone call and linkage-to-care-based intervention increases mammography uptake among primary care patients at an urban safety-net hospital

Getty Images

News | Mammography | May 22, 2020
May 22, 2020 — Telephone outreach coupled with scheduling assistance significantly increased...
The Breast Imaging and Reporting System (BI-RADS) was established by the American College of Radiology to help classify findings on mammography. Findings are classified based on the risk of breast cancer, with a BI-RADS 2 lesion being benign, or not cancerous, and BI-RADS 6 representing a lesion that is biopsy-proven to be malignant.

Getty Images

News | Breast Imaging | May 19, 2020
May 19, 2020 — Women with mammographically detected breast lesions that are probably benign should have follow-up sur
Podcast: Impact of COVID-19 on Breast Cancer Treatment with Dr. Andrea Madrigrano

Kubtec hosts a Podcast: Impact of COVID-19 on Breast Cancer Treatment with Andrea Madrigrano, M.D., as part of its public service campaign.

News | Coronavirus (COVID-19) | May 06, 2020
May 6, 2020 — The COVID-19 pandemic is an unprec
The American Society of Breast Surgeons (ASBrS), the National Accreditation Program for Breast Centers (NAPBC), the National Comprehensive Cancer Network (NCCN), the Commission on Cancer (CoC) of the American College of Surgeons, and the American College of Radiology (ACR) have released new joint recommendations for prioritization, treatment and triage of breast cancer patients during the coronavirus (COVID-19) pandemic

Getty Images

News | Breast Imaging | April 13, 2020
April 13, 2020 — The American Society of Breast Surgeons (...